II.5 Tamoxifen and other genital tissues: Vagina, cervix and ovaries

European Journal of Cancer

Volumn 34, Issue SUPPL. 4, 1998, Pages

  Cohen, I ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CELL MATURATION; CONFERENCE PAPER; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN EXPERIMENT; OVARY CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING; UTERINE CERVIX CANCER;

EID: 0031692113     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00094-X     Document Type: Conference Paper

References (10)

1. Ferrazzie E, Cartei G, Mattarazzo R, Fiorentino M. Oestrogen-like effect of tamoxifen on vaginal epithelium. Br Med J 1977, i, 1351-1352.
2. Boccardo F, Berazzi P, Rubagotti A, et al. Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 1981, 38, 281-285.
3. Yokosuka K, Teshima H, Kstase K, et al. Effects of long-term administration of tamoxifen on vaginal epithelium and complications of endometrial lesions in breast cancer patients. Nippon-Sanka Fujinka Gakkai Zasshi 1985, 47, 125-132.
4. Lahti E, Vuopala S, Kauppila A, et al. Moderation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long term tamoxifen. Gynecol Oncol 1994, 55, 410-414.
5. Fornander T, Cedermork B, Mattsson A, et al. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancer. Lancet 1984, 21, 117-120.
6. Andersson M, Storm HH, Mouridsen HT. Incidence of new primary cancer after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 1991, 83, 1013-1017.
7. Rutqvist LE, Johansson H, Signomaklo T, et al. Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. J Natl Cancer Inst 1995, 87, 645-651.
8. Cohen I, Beyth Y, Tepper R, et al. Ovarian tumours in post menopausal breast cancer patients treated with tamoxifen. Gynecol Oncol 1996, 60, 54-58.
9. Kedar RP, Bourne TH, Powles TH, et al. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomized breast cancer prevention trial. Lancet 1994, 343, 1318-1321.
10. Cohen I, Altaras MM, Beyth Y, et al. Ovarian volume in postmenopausal breast cancer patients treated with tamoxifen. Gynecol Oncol 1996, 64, 105-108.